TLR10: Insights, controversies and potential utility as a therapeutic target

Area of Science:

• Immunology
• Molecular Biology
• Cell Signaling

Background:

• The Toll-like receptor (TLR) family is critical for innate and acquired immunity.
• Toll-like receptor 10 (TLR10) is poorly understood, with conflicting data on its functions.
• TLR10's role in immune responses is complex, potentially mediating both pro- and anti-inflammatory effects.

Purpose of the Study:

• To summarize recent findings on the dual pro- and anti-inflammatory roles of TLR10.
• To review the molecular pathways implicated in TLR10 signaling.
• To highlight TLR10's potential as a therapeutic target for inflammatory and immune-related diseases.

Main Methods:

• Review of existing literature on TLR10 ligands, dimerization, and signaling pathways.
• Analysis of studies investigating TLR10's effects on cytokine production.
• Examination of research on TLR10 gene polymorphisms and their impact on immune responses.

Main Results:

• TLR10 can induce pro-inflammatory cytokines via homodimers or heterodimers with TLR1.
• TLR10 can inhibit pro-inflammatory responses when co-expressed with TLR2.
• Mutations and polymorphisms in TLR10 affect its signaling and influence susceptibility to diseases.

Conclusions:

• TLR10 possesses a dual role in immune regulation, acting as both a pro- and anti-inflammatory receptor.
• Further research into TLR10's ligands and functions is needed to fully elucidate its mechanisms.
• TLR10 represents a promising therapeutic target for managing inflammatory and immune disorders.